Informativa e consenso per l'uso dei cookie

Accetto Il nostro sito salva piccoli pezzi di informazioni (cookie) sul dispositivo, al fine di fornire contenuti migliori e per scopi statistici. È possibile disattivare l'utilizzo di cookies modificando le impostazioni del tuo browser. Continuando la navigazione si acconsente all'utilizzo dei cookie.

265651-18-1 - O-(N-Succinimidyl)-N,N,N',N'-tetramethyluronium hexafluorophosphate, 98+% - N,N,N',N'-Tetramethyl-O-(N-succinimidyl)uronium hexafluorophosphate - HSTU - H54035 - Alfa Aesar

H54035 O-(N-Succinimidyl)-N,N,N',N'-tetramethyluronium hexafluorophosphate, 98+%

Codice CAS
265651-18-1
Sinonimi
N,N,N',N'-Tetramethyl-O-(N-succinimidyl)uronium hexafluorophosphate
HSTU

Dimensioni Prezzo ($) Quantità Disponibilità
1g 36,72
5g 146,70
25g 560,41
Aggiungi al carrello Aggiungi al preventivo generale Visualizza articolo

O-(N-Succinimidyl)-N,N,N',N'-tetramethyluronium hexafluorophosphate, 98+%

MDL
MFCD01863753

Proprietà chimiche

Formula
C9H16F6N3O3P
Peso formula
359.21
Punto di fusione
ca 220° dec.
Sensibilità
Moisture Sensitive
Solubilità
Soluble in acetonitrile 0.5 g/mL.

Applicazioni

Coupling reagent for peptide synthesis and the formation of other amides. Reactant for synthesis of liposomal contrast agents for magnetic resonance imaging, synthesis of protein labeling molecules, synthesis of thiol-reactive Cy5 derivatives.

Note

Moisture sensitive. Store under inert gas. Store away from oxidizing agents, water/ moisture.

Letteratura

H J Gruber; G Kada; B Pragl; C Riener; C D Hahn; G S Harms; W Ahrer; T G Dax; K Hohenthanner; H G Knaus. Preparation of thiol-reactive Cy5 derivatives from commercial Cy5 succinimidyl ester. Bioconjugate Chemistry. 2000, 11 (2), 161-166.

Sjoerd Hak; Honorius M H F Sanders; Prashant Agrawal; Sander Langereis; Holger Grüll; Henk M Keizer; Francesca Arena; Enzo Terreno; Gustav J Strijkers; Klaas Nicolay. A high relaxivity Gd(III)DOTA-DSPE-based liposomal contrast agent for magnetic resonance imaging. European Journal of Pharmaceutics and Biopharmaceutics. 2009, 72 (2), 397-404.

Rischio GHS e dichiarazioni precauzionali

Dichiarazioni di rischio (UE): H315-H319-H335

Causes skin irritation. Causes serious eye irritation. May cause respiratory irritation.

Dichiarazioni precauzionali: P261-P280-P305+P351+P338-P304+P340-P362-P312-P321-P405-P403+P233-P501a

Avoid breathing dust/fume/gas/mist/vapours/spray. Wear protective gloves/protective clothing/eye protection/face protection. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. IF INHALED: Remove to fresh air and keep at rest in a position comfortable for breathing. Take off contaminated clothing and wash before reuse. Call a POISON CENTER or doctor/physician if you feel unwell. Specific treatment (see label). Store locked up. Store in a well-ventilated place. Keep container tightly closed. Dispose of contents/container in accordance with local/regional/national/international regulations.

Altri riferimenti

Codice tariffe armonizzato
2925.19
TSCA
No

Raccomandato

  • A12412

    2-Bromobenzylamine, 98%
  • L17956

    5-(3-Benzyloxyphenyl)-1H-tetrazole, 99%
  • A12626

    Tetra-n-butylammonium hydroxide, 40% w/w in methanol
  • L07948

    2-Thioisochroman-4-one, 98%
  • H54221

    2-Chloro-5-(ethylcarbamoyl)benzeneboronic acid, 97%

Visualizzati di recente

Prodotti chimici

Scienze della vita

Metalli e materiali

Catalizzatori

Apparecchiature di analisi e di laboratorio